| Literature DB >> 26504015 |
Gabriella Spengler1, Imre Ocsovszki2, Ádám Szabó Tönki1, Ryosuke Saijo3, Genki Watanabe3, Masami Kawase4, Joseph Molnár1.
Abstract
Efflux pump inhibitors are attractive compounds that reverse multidrug resistance (MDR) in cancer cells. In the present study, 10 phosphorus ylides (P-ylides) were compared based on their MDR-reverting activity in human ATP-binding cassette sub-family B member 1 (ABCB1; P-glycoprotein) gene-transfected L5178Y mouse T-lymphoma cells. Among them, three P-ylides, Ph3P=C(COCF3)COPh, Ph3P=C(COC2F5)COPh and Ph3P=C(COC3F7)COPh were identified as selectively modulating the ABCB1 pump. These compounds, with low cytotoxicity against mouse T-lymphoma cells, exhibited more potency than the positive control ABCB1 inhibitor verapamil. CopyrightEntities:
Keywords: ABCB1; Multidrug resistance; P-glycoprotein; mouse T-lymphoma; phosphorus ylide; trifluoroacetyl
Mesh:
Substances:
Year: 2015 PMID: 26504015
Source DB: PubMed Journal: Anticancer Res ISSN: 0250-7005 Impact factor: 2.480